Privately held biotechnology company NGM Bio announced the start of a Phase 1 clinical trial to study an antibody that could potentially treat patients with type 2 diabetes, obesity and nonalcoholic steatohepatitis.
Supply Chain
Women with advanced HER2-positive breast cancer respond to a less expensive experimental drug just as well as the standard drug Herceptin, according to a recent study.
Medtronic recently acquired Minneapolis-based Responsive Orthopedics, a start-up company that specializes in selling devices to hospitals involved in government cost-cutting programs.
A new report from Silicon Valley, Calif.-based Hospital Pricing Specialists shows the cost of one milligram of the common opioid overdose antidote naloxone hydrochloride is increasing at an alarming rate.
Shares of Laval, Quebec, Canada-based Valeant Pharmaceuticals International plummeted Tuesday after new CEO Joseph Papa cut 2016 earnings and sales forecasts as the company attempts to reset, according to Bloomberg.
Advertisement
Researchers at King's College London developed a blood test that can accurately predict whether a patient will respond to conventional antidepressants on the market.
Orthopedic implant company MẌ Orthopedics recently earned FDA approval for its dynaMẌ Nitinol Compression Screw.
The price of a one milligram Naloxone Hydrochloride injection, used as an antidote to an opioid overdose, continues to soar.
CRISPR, which stands for "clustered regularly interspaced short palindromic repeats," are segments of prokaryotic DNA that contain brief repetitions of base sequences.
Future Market Insights recently studied the wearable medical devices market. Here are five things to know about market activity: